CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.160
+0.280 (31.79%)
At close: May 15, 2026, 4:00 PM EDT
0.9901
-0.1700 (-14.65%)
After-hours: May 15, 2026, 7:59 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $13.73 million as of May 15, 2026. Its market cap has decreased by -49.81% in one year.
Market Cap
13.73M
Enterprise Value
12.47M
1-Year Change
-49.81%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $13.73M, a decrease of -70.24%. That is a compound annual growth rate of -32.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 13.73M | -10.90% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 14.82M |
| Lexaria Bioscience | 14.68M |
| IN8bio | 14.67M |
| Theriva Biologics | 13.35M |
| Vyome Holdings | 13.27M |
| Cyclerion Therapeutics | 13.19M |
| Cellectar Biosciences | 13.10M |
| BioLineRx | 12.52M |